Top news of the week: 28.07.2021.
Companies And Industries
Clinical Catch-Up: July 19-23
It was another busy week for clinical trial updates. Here’s a look at some including Mesoblast Limited, CytoDyn, Magenta Therapeutics and more.
Create Value & Success Will Follow, Anima Biotech CEO Yochi Slonim Says
“When big pharma collaborates with biopharma companies, the main risk isn’t the technology, but the commitment of the partner,” according to serial entrepreneur Yochi Slonim, CEO of Anima ...
Biotech Companies Announce Big Drug Wins with FDA
Several biotech and biopharmaceutical companies have announced new wins with the FDA, ranging from cancer treatment candidates to investigational agents for opioid use disorder.
PerkinElmer Continues Rapid Life Science Growth with Massive $5.25B Acquisition
It's been a long season of acquisitions for PerkinElmer. Now in its largest purchase ever, the company is buying biomedical research tool company BioLegend.
Good Day BIO: COVAX Marketplace will boost global vaccine production
Lots of newness today: the new COVAX Marketplace, BIO’s new VP for Agriculture and Environment, and more news from Washington. (888 words, 4 minutes, 26 seconds)
IPO Raises $304M for Caribou, Developer of Gene-Edited Cell Therapies
Caribou Biosciences, the developer of gene-edited cell therapies co-founded by Nobel laureate Jennifer Doudna, PhD, has launched an upsized initial public offering that raised $304 million ...
Fel d 1 Protein Sparking Curiosity that Could Change the Cat
Companies such as Indoor Biotechnologies in Virginia are leveraging cutting-edge scientific techniques to not only reduce the amount of the protein expressed but completely knock it out.
PerkinElmer to Acquire Antibody, Reagent Maker BioLegend for $5.25B
PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock, in a deal designed to position ...